GET DAILY SIGNALSIVW vs SCHG: Weighing the Trade-Offs Between Two Popular Large-Cap Growth ETFs
Key Takeaways
- Both IVW and SCHG are passively managed, large-cap U.S. growth funds, but they track different indexes and differ meaningfully in cost, concentration, and diversification.
- IVW charges an expense ratio of 0.18%, while SCHG charges 0.04% — a structural cost advantage that compounds over long holding periods.
- SCHG holds roughly 200 stocks versus about 150 for IVW, and its top-10 concentration is lower, reducing single-name risk.
- IVW is more heavily weighted to mega-cap technology leadership, led by NVDA, giving it higher sensitivity to semiconductor and artificial intelligence momentum.
- Both funds remain highly exposed to the technology and communication services sectors, making them vulnerable to the same rotation and interest-rate dynamics.
- Tickeron AI Verdict: SCHG — superior cost efficiency, broader diversification, and lower concentration give it the structural edge in this comparison.
Why These Two Growth ETFs Stand Out
Investors looking for exposure to America’s most innovative and fastest-growing large companies often consider two of the market’s leading growth exchange-traded funds: the iShares S&P 500 Growth ETF (IVW) and the Schwab U.S. Large-Cap Growth ETF (SCHG). Both pursue the same broad goal of capturing the large-cap growth segment of the U.S. equity market, yet they follow different indexes, carry different costs, and exhibit different concentration profiles. With mega-cap technology, artificial intelligence spending, and shifting interest-rate expectations continuing to influence leadership, understanding these differences helps in constructing a more resilient portfolio.
iShares S&P 500 Growth ETF (IVW) at a Glance
IVW, issued by BlackRock and launched in May 2000, tracks the S&P 500 Growth Index. The index applies three growth factors—sales growth, the ratio of earnings change to price, and momentum—to identify the growth portion of the S&P 500. The fund holds roughly 150 stocks and uses an optimized sampling method to track its benchmark.
Concentration remains a notable characteristic. As of recent data, NVDA represented about 14–15% of assets, followed by MSFT near 10%, AAPL around 6–7%, and the combined GOOGL/GOOG share classes near 10%. Other prominent holdings include AVGO, META, and AMZN. The top ten holdings account for roughly 60% of the fund. Sector exposure is led by information technology at over 50%, with communication services near 15%, financials around 9%, and consumer discretionary and healthcare in the mid-single digits. The net expense ratio stands at 0.18%.
Schwab U.S. Large-Cap Growth ETF (SCHG) at a Glance
SCHG, sponsored by Charles Schwab and launched in December 2009, tracks the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. This benchmark draws growth stocks from the 750 largest U.S. companies by market capitalization, a wider universe than the S&P 500. The fund holds roughly 200 securities and generally uses full replication.
While top holdings overlap significantly with IVW, concentration is lower. NVDA and AAPL each sit near 10%, followed by MSFT around 7%, AMZN near 5%, and AVGO, LLY, and AMD each in the low single digits. The top ten holdings represent roughly 51% of assets. Information technology remains the largest sector at roughly 47–54%, with communication services, consumer discretionary, and healthcare each more prominent than in IVW. The net expense ratio is 0.04%, among the lowest in the category.
The Broader Industry and Thematic Context
Both funds sit squarely within the ongoing artificial intelligence and cloud-computing cycle, where semiconductor and mega-cap software names have driven a large portion of returns. Strong demand for accelerated computing, data-center expansion, and generative AI applications has supported earnings growth in the largest technology holdings. At the same time, both remain sensitive to interest-rate expectations because long-duration growth equities tend to re-rate when discount rates change.
Capital continues to flow into low-cost, broad growth exposure, while concentration risk in the largest names has attracted more regulatory and investor attention. Healthcare innovation, particularly weight-loss therapeutics, has provided an additional growth driver through holdings such as LLY. Key risks include valuation compression, a shift toward value or defensive sectors, and any slowdown in AI-related spending. I also checked sector weightings using Tickeron’s AI Screener to see how the two funds compare within the broader technology and healthcare landscape.
Performance and Positioning Side by Side
Over recent market cycles, IVW and SCHG have delivered broadly similar results given their overlapping mega-cap growth exposure, though they have diverged on the margin. IVW’s higher weighting to NVDA and the semiconductor complex has amplified gains during AI-driven rallies and also increased drawdowns during technology sell-offs. SCHG’s greater breadth across healthcare, consumer discretionary, and financials has historically offered a slightly smoother profile.
Relative positioning favors SCHG on a risk-adjusted basis: lower cost, more holdings, and reduced top-heavy concentration have helped mitigate single-name shocks. IVW, by contrast, provides a more concentrated, aggressive tilt toward large-cap growth leadership. Both remain highly correlated to the technology sector and will continue to track the same macro drivers—earnings cycles among top holdings, Federal Reserve policy expectations, and the durability of AI capital investment.
Using AI Tools in My Research Process
From what I see, tools like Tickeron’s AI Trend Prediction Engine can add useful context when evaluating how these ETFs might behave under different market regimes. I’m watching this closely because even small differences in cost and concentration can compound meaningfully over a multi-year horizon.
Why SCHG Holds the Structural Edge
In a direct comparison, the structural characteristics point to SCHG as the stronger choice for most long-term investors. It delivers a substantially lower expense ratio (0.04% versus 0.18%), a broader portfolio of roughly 200 holdings, and lower top-ten concentration. These factors improve long-term, risk-adjusted durability relative to IVW. While IVW offers more concentrated exposure to semiconductor and mega-cap momentum, SCHG’s cost efficiency and diversification profile provide a more favorable foundation, especially for investors with longer time horizons. This view reflects current fund characteristics and market conditions and could shift as trends and valuations evolve.
Tickeron AI Tools in Practice
When comparing ETFs like these, I often turn to Tickeron’s AI Screener to quickly filter holdings, sector exposures, and performance metrics across similar funds. It helps surface differences in concentration and cost that might otherwise take longer to identify manually, allowing me to focus on the factors that matter most for portfolio construction.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
IVW's RSI Indicator ascending out of oversold territory
The RSI Indicator for IVW moved out of oversold territory on October 26, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 25 of the 25 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 49 cases where IVW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
Following a +1.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where IVW advanced for three days, in 296 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
IVW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 334 of 373 cases where IVW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IVW as a result. In 67 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for IVW turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 42 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
IVW moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IVW crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category LargeGrowth
Advertisement